Tsunenobu Wakamatsu
Kagoshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tsunenobu Wakamatsu.
International Journal of Cancer | 2012
Tomofumi Hamada; Tsunenobu Wakamatsu; Mayumi Miyahara; Satoshi Nagata; Masahiro Nomura; Yoshiaki Kamikawa; Norishige Yamada; Surinder K. Batra; Suguru Yonezawa; Kazumasa Sugihara
MUC4 mucin is now known to be expressed in various normal and cancer tissues. We have previously reported that MUC4 expression is a novel prognostic factor in several malignant tumors; however, it has not been investigated in oral squamous cell carcinoma (OSCC). The aim of our study is to evaluate the prognostic significance of MUC4 expression in OSCC. We examined the expression profile of MUC4 in OSCC tissues from 150 patients using immunohistochemistry. Its prognostic significance in OSCC was statistically analyzed. MUC4 was expressed in 61 of the 150 patients with OSCC. MUC4 expression was significantly correlated with higher T classification (p = 0.0004), positive nodal metastasis (p = 0.049), advanced tumor stage (p = 0.002), diffuse invasion of cancer cells (p = 0.004) and patients death (p = 0.004) in OSCC. Multivariate analysis showed that MUC4 expression (p = 0.011), tumor location (p = 0.032) and diffuse invasion (p = 0.009) were statistically significant risk factors. Backward stepwise multivariate analysis demonstrated MUC4 expression (p = 0.0015) and diffuse invasion (p = 0.018) to be statistically significant independent risk factors of poor survival in OSCC. The disease‐free and overall survival of patients with MUC4 expression was significantly worse than those without MUC4 expression (p < 0.0001 and p = 0.0001). In addition, the MUC4 expression was a significant risk factor for local recurrence and subsequent nodal metastasis in OSCC (p = 0.017 and p = 0.0001). We first report MUC4 overexpression is an independent factor for poor prognosis of patients with OSCC; therefore, patients with OSCC showing positive MUC4 expression should be followed up carefully.
Japanese Journal of Oral & Maxillofacial Surgery | 1989
Masashi Yoshida; Hiroshi Mukai; Yuichi Tomori; Tsunenobu Wakamatsu; Sukehide Yamashita
J.Jpn.Stomatol.Soc | 1994
Haruyuki Imamura; Hiroshi Mukai; Tsunenobu Wakamatsu; Kiyomi Kawashima; Kimiyasu Takagi; Fumihiko Kinjo; Sukehide Yamashita
Japanese Journal of Oral & Maxillofacial Surgery | 1990
Tohru Yamaguchi; Kazumasa Sugihara; Makoto Fujisaki; Tsunenobu Wakamatsu; Akirou Ohkubo; Sukehide Yamashita
Japanese Journal of Oral & Maxillofacial Surgery | 1990
Tsunenobu Wakamatsu; Hiroshi Mukai; Kiyomi Kawashima; Akiro Okubo; Sukehide Yamashita
Oral Therapeutics and Pharmacology | 1989
Hiroshi Mukai; Kiyomi Kawashima; Tsunenobu Wakamatsu; Akirou Ookubo; Kazumasa Sugihara; Sukehide Yamashita
Japanese Journal of Oral & Maxillofacial Surgery | 1989
Motoo Kitano; Ichiro Senba; Gabriel Landini; Michihiko Maruo; Makoto Narita; Hiroshi Mukai; Tsunenobu Wakamatsu; Kiyomi Kawashima; Sukehide Yamashita
Japanese Journal of Oral & Maxillofacial Surgery | 1987
Mariko Yamashita; Kazumasa Sugihara; Akirou Ohkubo; Masaaki Kawada; Tsunenobu Wakamatsu; Sukehide Yamashita
Japanese Journal of Oral & Maxillofacial Surgery | 1987
Koujirou Yamaguchi; Hiroshi Mukai; Kiyomi Kawashima; Makoto Fujisaki; Tsunenobu Wakamatsu; Sukehide Yamashita; Tsuyoshi Satou; Takenori Noikura
Japanese Journal of Oral and Maxillofacial Surgery | 1986
Tsunenobu Wakamatsu; Hiroshi Mukai; Yuuichi Tomori; Hiroshi Nagata; Sukehide Yamashita